×
Safety and Efficacy of Long-Acting Risperidone in Schizophrenia: A 12-Week, Multicenter, Open-Label Study in Stable Patients Switched From Typical and Atypical Oral Antipsychotics PDF
$ 40.00
Safety and Efficacy of Long-Acting Risperidone in Schizophrenia: A 12-Week, Multicenter, Open-Label Study in Stable Patients Switched From Typical and Atypical Oral Antipsychotics PDF quantity
$ 40.00
×
Executive Function Predicts Response to Antiaggression Treatment in Schizophrenia: A Randomized Controlled Trial PDF
$ 40.00
Executive Function Predicts Response to Antiaggression Treatment in Schizophrenia: A Randomized Controlled Trial PDF quantity
$ 40.00
×
Adherence to Pharmacotherapy in Bipolar Disorder Patients With and Without Co-Occurring Substance Use Disorders PDF
$ 40.00
Adherence to Pharmacotherapy in Bipolar Disorder Patients With and Without Co-Occurring Substance Use Disorders PDF quantity
$ 40.00
×
To Scan or Not to Scan: Horses and Zebras PDF
$ 40.00
To Scan or Not to Scan: Horses and Zebras PDF quantity
$ 40.00
×
Baseline Characteristics and Early Response at Week 1 Predict Treatment Outcome in Adolescents With Bipolar Manic or Mixed Episode Treated With Olanzapine: Results From a 3-Week, Randomized, Placebo-Controlled Trial PDF
$ 40.00
Baseline Characteristics and Early Response at Week 1 Predict Treatment Outcome in Adolescents With Bipolar Manic or Mixed Episode Treated With Olanzapine: Results From a 3-Week, Randomized, Placebo-Controlled Trial PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart